search
Back to results

Trial to Reduce Wound Infection With Contralateral Drainage in Loop Ileostomy Closure

Primary Purpose

Surgical Wound Infection

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
application of a contralateral drainage (Penrose ® device)
Sponsored by
Corporacion Parc Tauli
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Surgical Wound Infection focused on measuring superficial surgical site infection, loop ileostomy, Ileostomy closure

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Any patient carrying loop ileostomy due to low anterior resection for rectal cancer.
  • Over 18 years.
  • Surgery scheduled.
  • Informed consent signed.

Exclusion Criteria:

Patients with terminal ileostomy.

  • Patients with loop ileostomy different from any surgery of rectal cancer.
  • To require another surgical procedure added.
  • Urgent surgery.
  • Patient refusal to participate in the study.

Sites / Locations

  • Hospital Universitario Parc Tauli de Sabadell

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control Group

Drainage Group

Arm Description

Patients with primary loop ileostomy closure without drainage of the surgical wound

Patients with the application of a contralateral drainage (Penrose ®) in surgical wound of primary loop ileostomy closure. Intervention: application of a contralateral drainage in surgical wound closure.

Outcomes

Primary Outcome Measures

Number of patients with surgical site infection after ileostomy closure depending if there is or not a penrose drainage application

Secondary Outcome Measures

Number of patients with hematoma after ileostomy closure surgery
Number of patients with seroma after ileostomy closure surgery
Number of patients with anastomotic leak after ileostomy colsure surgery

Full Information

First Posted
March 18, 2013
Last Updated
April 17, 2019
Sponsor
Corporacion Parc Tauli
search

1. Study Identification

Unique Protocol Identification Number
NCT02574702
Brief Title
Trial to Reduce Wound Infection With Contralateral Drainage in Loop Ileostomy Closure
Official Title
Prospective Randomized Controlled Trial to Reduce the Superficial Surgical Site Infection Due to a Contralateral Drainage Application in Loop Ileostomy Closure
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
February 2013 (Actual)
Primary Completion Date
June 2016 (Actual)
Study Completion Date
July 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Corporacion Parc Tauli

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Introduction: The most common complication of loop ileostomies closure for rectal cancer patients undergoing a low anterior rectum resection, is the superficial surgical site infection (incidence 2-40%). There are various techniques related to closing loop ileostomy. In a retrospective study at our center, the investigators objectify that superficial surgical site infection rate was reduced by more than a half by the application of a contralateral drainage (Penrose ®) in primary loop ileostomy closure. Objectives and Hypothesis: Hypothesis: The application of a contralateral drainage (Penrose ®) in primary loop ileostomy closure (in carriers of loop ileostomy by a low anterior rectum resection for rectal cancer) reduces the superficial surgical site infection. Main objective: To reduce the rate of superficial surgical site infection by the application of a contralateral drainage (Penrose ®) in surgical wound of primary loop ileostomy closure. Methodology: Prospective and randomized clinical trial on the effectiveness of contralateral Penrose® drainage implementation in those patients that have a primary loop ileostomy (by low anterior rectum resection) closure to be able to know if the investigators can reduce the superficial surgical site infection rate. Monitorization until 30 days after surgery
Detailed Description
Introduction: The most common complication of loop ileostomies closure for rectal cancer patients undergoing a low anterior rectum resection, is the superficial surgical site infection (incidence 2-40%). In the literature there are various techniques related to closing loop ileostomy that try to reduce the rate of infections recorded. In a retrospective study at our center, the investigators objectify that superficial surgical site infection rate was reduced by more than a half by the application of a contralateral drainage (Penrose ®) in primary loop ileostomy closure. Objectives and Hypothesis: Hypothesis: The application of a contralateral drainage (Penrose ®) in primary loop ileostomy closure (in carriers of loop ileostomy by a low anterior rectum resection for rectal cancer) reduces the superficial surgical site infection. Main objective: To reduce the rate of superficial surgical site infection by the application of a contralateral drainage (Penrose ®) in surgical wound of primary loop ileostomy closure. Secondary objectives: Identify risk factors associated with superficial surgical site infection in relation to a primary loop ileostomy closure (with or without drainage). Reducing hospital stay and care at home. Methodology: Prospective and randomized clinical trial on the effectiveness of contralateral Penrose® drainage implementation in those patients that have a primary loop ileostomy (by low anterior rectum resection) closure to be able to know if the investigators can reduce the superficial surgical site infection rate. It will be used a simple randomization. To assess the occurrence of superficial incisional infection, the investigators will be monitoring patients till 30 days after surgery

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgical Wound Infection
Keywords
superficial surgical site infection, loop ileostomy, Ileostomy closure

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
78 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Patients with primary loop ileostomy closure without drainage of the surgical wound
Arm Title
Drainage Group
Arm Type
Experimental
Arm Description
Patients with the application of a contralateral drainage (Penrose ®) in surgical wound of primary loop ileostomy closure. Intervention: application of a contralateral drainage in surgical wound closure.
Intervention Type
Procedure
Intervention Name(s)
application of a contralateral drainage (Penrose ® device)
Intervention Description
application of a contralateral drainage (Penrose ®) in surgical wound of primary loop ileostomy closure
Primary Outcome Measure Information:
Title
Number of patients with surgical site infection after ileostomy closure depending if there is or not a penrose drainage application
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Number of patients with hematoma after ileostomy closure surgery
Time Frame
30 days
Title
Number of patients with seroma after ileostomy closure surgery
Time Frame
30 days
Title
Number of patients with anastomotic leak after ileostomy colsure surgery
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Any patient carrying loop ileostomy due to low anterior resection for rectal cancer. Over 18 years. Surgery scheduled. Informed consent signed. Exclusion Criteria: Patients with terminal ileostomy. Patients with loop ileostomy different from any surgery of rectal cancer. To require another surgical procedure added. Urgent surgery. Patient refusal to participate in the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xavier Serra-Aracil, MD
Organizational Affiliation
Hospital Universitario Parc Tauli de Sabadell
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitario Parc Tauli de Sabadell
City
Sabadell
State/Province
Barcelona
ZIP/Postal Code
08208
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
30824960
Citation
Serracant A, Serra-Aracil X, Mora-Lopez L, Pallisera-Lloveras A, Serra-Pla S, Zarate-Pinedo A, Navarro-Soto S. The Effectiveness of Contralateral Drainage in Reducing Superficial Incisional Surgical Site Infection in Loop Ileostomy Closure: Prospective, Randomized Controlled Trial. World J Surg. 2019 Jul;43(7):1692-1699. doi: 10.1007/s00268-019-04972-6.
Results Reference
derived

Learn more about this trial

Trial to Reduce Wound Infection With Contralateral Drainage in Loop Ileostomy Closure

We'll reach out to this number within 24 hrs